Categories
Pharmaceutical

Rising Fashion And Cosmetic Industry Is Projected To Boost Demand For Potent Serum-Based Creams for Anti-Aging Skincare Serum Market, Says Fact.MR

According to Fact MR’s recent market research, the skincare market is the leading segment of the cosmetic industry, accounting for approximately 36% of the global cosmetic market. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, Skincare Serums market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

The report covers exhaustive analysis on:

  • Skincare Serums Market Segments
  • Skincare Serums Market Dynamics
  • Skincare Serums Market Size
  • Skincare Serums Market Supply & Demand
  • Skincare Serums Market Current Trends/Issues/Challenges
  • Skincare Serums Competition & Companies involved
  • Technology
  • Value Chain

Request a report brochure to gain detailed insights at https://www.factmr.com/connectus/sample?flag=B&rep_id=3973

Digital Transformation in Healthcare Presenting Opportunities for Skincare Serums Market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the xyz market.

Report Benefits & Key Questions Answered

  • Skincare Serums Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Skincare Serums Historical volume analysis: The report provides a comparison of Skincare Serums’s historical sales and projected sales performance for 2021-2031.
  • Skincare Serums Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Skincare Serums market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Skincare Serums Consumption by demographics: The report investigates consumer behavior affecting Skincare Serums demand outlook for the assessment period. Effect of their keenness for digital trends on Skincare Serums market is carefully analyzed
  • Post COVID consumer spending on Skincare Serums: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Skincare Serums market growth.

 

Speak To Our Analyst: https://www.factmr.com/connectus/sample?flag=EB&rep_id=3973

Competitive Landscape Analysis

The study offers insights into key trends affecting healthcare industry, subsequently influencing demand supply forces in the Skincare Serums market. To study competitive trends, it profiles some of the leading market players profiling leading players including Some of the key players in the global skincare serums market are

  • EMK Products LLC
  • IT Cosmetics LLC
  • Crop Infrastructure Corp
  • Philosophy Inc
  • First Aid Beauty Ltd
  • Philosophy Inc
  • Loral Group
  • Ester Lauder Companies
  • Amway
  • Proctor and Gamble and Unilever.

To offer an in-depth analysis of prevailing competition, the report offers a detailed market share analysis. Strategies adopted by players across these categories and impact of the same on the overall market are studied at length.

Based on product type, the global Skincare serums market is segmented as:

  • Anti-Aging Serum
  • Skin Whitening Serum
  • Anti-Acne Serum
  • Glowing Skin Serum
  • Anti-Blemish Serum
  • Others

Based on skin type, the global Skincare serums market is segmented as:

  • Dry Skin
  • Sensitive Skin
  • Oily Skin

Based on gender, the global Skincare serums market is segmented as:

  • Female
  • Male

Get Customization on this Report for Specific Research Solutions https://www.factmr.com/connectus/sample?flag=RC&rep_id=3973

Based on ingredient, the global Skincare serums market is segmented as:

  • Hyaluronic Acid
  • Vitamin C
  • Retinol (Vitamin A)
  • Alpha Hydroxy Acids (AHAs)
  • Vitamin E
  • DMAE (Dimethylaminoethanol)
  • Peptides
  • Glycerin
  • Others

Based on distribution channel, the global Skincare Serums market is segmented as:

  • Institutional Sales
  • Hospitals
  • Dermatology Clinics
  • Retail Sales
  • Drug Stores
  • Retail Stores
  • Super Market
  • Online Pharmacies

Read Fact.MR Exclusive Article on Transplant Pathogen Monitoring Market to Double in Next Years – https://www.biospace.com/article/transplant-pathogen-monitoring-market-to-double-in-next-years-pushing-the-revenue-over-us-500-mn-by-2031-fact-mr/

Explore Fact.MR’s Coverage on the Healthcare Domain

Stress Urinary Incontinence Market– The introduction of innovative urinary catheters coupled with rising preference for minimal invasive surgical treatment of stress urinary incontinence to achieve early cure has registered to be prominent driving factor responsible for revenue generation in global stress urinary incontinence market.

ACL Reconstruction Market– The growing prevalence and recurrence of injuries caused by sports is expected to be the major factor driving the growth of the ACL Reconstruction market over the forecast period.

Allergic Rhinitis Treatment Device Market– The global allergic rhinitis treatment device market for is a fragmented market having a low technological intensity and a lower volume of sale resulting in low pricing premium.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact: 

Sudip Saha

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

E: sales@factmr.com

Corporate Headquarter  

Future Market Insights,

1602-6 Jumeirah Bay X2 Tower,

Plot No: JLT-PH2-X2A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

Categories
Pharmaceutical

Biotechnology And Pharmaceutical Industry Is Registers As Prominent End User Segment In Membrane Protein Characterization Service Market

250 Pages Membrane Protein Characterization Service Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider Offers In-depth Insights into Membrane Protein Characterization Service Market

Fact.MR in its latest market research forecasts that the sales of Membrane Protein Characterization Service will increase in between 2021 and 2031. Owing to the growing demand for technologically advanced medical devices across healthcare sector the report on Membrane Protein Characterization Service Market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.. The survey offers compelling insights into key trends, growth drivers, market restraints and key strategies adopted by market players.

Request a report broucher to gain detailed insights at https://www.factmr.com/connectus/sample?flag=B&rep_id=3410

Increasing prevalence of diseases across the globe is generating huge demand for advanced healthcare system. As a result, more and more technologically advanced medical devices are being employed to aid medical Practitioners and professionals in medical setups. Sales of Membrane Protein Characterization Service devices are soaring rapidly.

 “Higher R&D focus and predicted rise in both investment and government incentives have created a conducive environment for surge in membrane protein characterization services. Demand is expected to remain high as pharmaceutical companies aim for more effective treatment and medicinal drugs from chronic ailments,” said a lead analyst at Fact MR.

 Membrane Protein Characterization Service Market Report Highlights:

  • Detailed overview of parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current, and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint

Membrane Protein Characterization Service Market: Segmentation

The global membrane protein characterization service market is classified on the basis of membrane protein type, service type, application, end user, and region.

Based on membrane protein type membrane protein characterization service market is segmented into following:

  • G Protein-Coupled Receptors (GPCRs)
  • Ion Channels
  • Membrane Receptors

Request for Customization of COVID-19 Impact on Membrane Protein Characterization Service Market – https://www.factmr.com/connectus/sample?flag=RC&rep_id=3410

Based on service type membrane protein characterization service market is segmented into following:

  • Biophysical characterization
  • Protein Thermal Shift Assay (PTSA)
  • Surface Plasmon Resonance (SPR)
  • Isothermal Titration Calorimetry (ITC)
  • Differential Scanning Calorimetry (DSC)
  • Saturation-Transfer Difference (STD)
  • Bio-Layer Interferometry (BLI) Technology
  • Thermal Gravimetric Analysis (TGA)
  • Mircoscale Thermophoresis (MST)
  • Anion Or Cation Exchange Chromatography
  • Liquid Chromatography
  • Gel Filtration
  • Transmission Electron Microscopy
  • Others

Based on application membrane protein characterization service market is segmented into following:

  • Drug Discovery & Development
  • Protein Engineering
  • Clinical Diagnosis
  • In vitro Diagnostics
  • Vaccine development
  • Antibody development

Based on end user membrane protein characterization service market is segmented into following:

  • Biotechnology and Pharmaceutical Industry
  • Research and Academic Institutes
  • Diagnostic Laboratories

Read More Trending Reports of Fact.MR:

https://www.biospace.com/article/membrane-protein-characterization-service-demand-surges-as-r-and-d-spending-increases-globally-study/

Explore Fact.MR’s Coverage on the Healthcare Domain

 Cancer Therapeutics Market: The global market for peptide-based cancer therapeutics is witnessing incremental growth at an astounding CAGR, and it is set to reach a valuation of US$ 11 billion in 2022.

Norovirus Treatment Market– Key players operating in the global norovirus treatment market are NIMRAJ CHEM AGROVET, Meda Pharmaceuticals Inc, Mizuno Pharmacies, Valeant Pharmaceuticals International, Inc.

Pectus Bar System Market– The global pectus bar system market is apprehended to see impressive growth in the near future due to rising patient pool, high adoption of minimally invasive repair of pectus excavatum and increasing incidence of pectus excavatum and other sternal deformities.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Medical Radiation Detection, Monitoring and Safety Market is expected to top a valuation of US$ 1.5 Bn by 2031

Fact.MR – a market research and competitive intelligence provider, projects the global medical radiation detection, monitoring and safety market to have a positive outlook, expanding at a CAGR of above 6% across the 2021-2031 forecast period.

The world is constantly advancing in technology to protect against the threat and issues of radiation with real-time and immediate results. Medical radiation detection, monitoring and safety equipment is applicable in nuclear medicine for the rapid identification of cancer. It is also used in the monitoring of fatal diseases through visual tracking.

Radiation detectors utilize the interaction of ionizing radiation to produce UV or visible light and are called scintillation detectors. In addition, these detectors provide information about energy distribution of incident radiation, and thus, can be utilized in spectrometers. Furthermore, hospitals, doctors, and dentists use a variety of nuclear materials to diagnose, monitor, and treat a wide assortment of metabolic process and medical condition in humans.

Request a report sample to gain compressive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=6505

Key Takeaways from Market Study
  • Global medical radiation detection, monitoring, and safety market to top US$ 1.5 Bn by 2031.
  • Personal dosimeters projected to reach valuation of around US$ 300 Mn by 2031.
  • Sales of environment radiation monitors projected to record around 3% CAGR over the next 10 years.
  • The market in Japan to record 3% CAGR over the forecast period of 2021- 2031.
  • China forecast to reach a projected market size above US$ 105 Mn by 2031.
  • The market in Canada projected to expand at above 4% CAGR over the next 10 years.

“With advancements in technology, the market has witnessed development of latest medical radiation detection, monitoring, and safety devices,” says a Fact.MR analyst.

medical radiation detection monitoring and safety market by FactMR

More Insights on the Global Medical Radiation Detection, Monitoring and Safety Sales Outlook

Fact MR provides an unbiased analysis of medical radiation detection, monitoring and safety market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the global demand for Medical Radiation Detection, Monitoring and Safety products with a detailed segmentation on the basis of:

Radiation and Monitoring Products
  • Personal Dosimeters
  • Area Process Monitors
  • Environmental Radiation Monitors
  • Surface Contamination Monitors
  • Radioactive Material Monitors

To gain in-depth insights on Medical Radiation Detection, Monitoring and Safety Market, request methodology at
https://www.factmr.com/connectus/sample?flag=RM&rep_id=6505

Detector
  • Gas-filled Detectors
  • Scintillators
  • Solid State Detectors
Safety
  • Full Body Protection
  • Face Protection
  • Hand Protection
Market Competition

Companies leverage strategic collaborative initiatives to increase their market share and profitability. Companies operating in the market are also acquiring start-ups working on radiation detection, monitoring, and safety technologies to strengthen their product capabilities.

  • In 2019, IBA Dosimetry launched myQA® iON, a unique environment for rapid and accurate cancer patient QA in proton therapy. myQA iON substantially reduces the required time for patient QA.
  • In 2019, Kromek launched the D3S PRD personal radiation detector. It is a high-speed SPRD (spectroscopic radiation detector) or PRD replacement that is a cost-effective radiation detection device, and puts a very powerful and sensitive radiation detector into the hands of first-line users.
  • In 2020, Thermofisher Scientific and Nano Pin Technologies Inc. collaborated to advance blood-based infectious disease detection technology through the development of highly sensitive liquid chromatography mass spectrometry (LC-MS)-based workflows.
Get More Insights-https://www.biospace.com/article/sales-of-medical-radiation-detection-monitoring-and-safety-products-to-grow-by-1-7x-through-2031/
More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the medical radiation detection, monitoring, and safety market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031.

The study divulges essential insights on the market on the basis of radiation and monitoring product (personal dosimeters, area process monitors, environmental radiation monitors, surface contamination monitors, and radioactive material monitors), detector (gas filled detectors, scintillators, and solid state detectors), safety (full body protection, face protection, and hand protection), and end user (hospitals, clinics, ambulatory surgical centers, and non-hospitals), across seven major regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa).

Explore Fact.MR’s Coverage on the Healthcare Domain

Genetic Testing Services Market – The future expansion of genetic testing services is heavily reliant on the advancement of information technology. Throughout the projected period, North America is expected to dominate the worldwide genetic testing services market. Increased demand for genetic testing to determine ancestry, as well as an increase in demand for in-vitro fertilization (IVF) and pre-implantation testing, are some of the primary reasons boosting market share. According to projections, the North American genetic testing market will account for over two-fifths of the total.

Rheumatoid Arthritis Stem Cell Therapy Market – Over the forecast period, the global market for rheumatoid arthritis treatments is expected to rise moderately. Over the projected period, the allogeneic mesenchymal stem cell segment is expected to lead the global rheumatoid arthritis stem cell therapy market. As the most accessible channel, hospitals are likely to account for a sizable portion of the global rheumatoid arthritis stem cell therapy market.

Serological Transplant Diagnostics Market – Serological transplant diagnosis, which is a critical component of successful and efficient organ transplantation, has grown rapidly in recent years. Growth in important distribution channels, such as hospitals and organ transplantation centres, to name a few, has boosted demand during the last five years, from 2016 to 2020, attracting more stakeholders to the business. Serological transplant diagnostic equipment sales are being fueled by an increase in incidence of serious lung, liver, and kidney disorders, as well as medical and diagnostic developments.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/medical-radiation-detection-monitoring-and-safety-market
Press Release: https://www.factmr.com/media-release/2102/global-medical-radiation-detection-monitoring-and-safety-trends

Categories
Pharmaceutical

Europe Diet Pills Market is projected to reach a value of US$ 868 Mn by 2031, Finds Fact.MR

According to a new report published by Fact.MR, a market research and competitive intelligence provider, the Europe diet pills market was valued at US$ 654 Mn in 2020, and is predicted to expand at a CAGR of around 2.6% over the forecast period (2021–2031).

Factors boosting demand for diet pills in Europe include rising incidence of type-2 diabetes, high cholesterol, and high blood pressure. Constant clinical trials for new medications will support market growth over the coming years. Moreover, growing health awareness is likewise driving developments in the market.

Currently, obesity is observed as a serious health concern, which leads to various other health problems. Diet pills are medicines used to slim down by losing weight along with exercise and an appropriate diet. With the growing trend of fitness in the young populous, there is increasing demand for these weight management products. These medicines act as a supplementary measure for weigh reduction other than routine regime of exercise and dietary patterns.

Request a report sample to gain comprehensive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=6494

Key Takeaways from Market Study
  • Glucomannan is expected to contribute more than 41% revenue share in the market by 2031.
  • Among all the drug type, demand for herbal supplements is expected to increase at a CAGR of 3% through 2031.
  • Appetite controlling pills dominate the market among the mechanisms, and are expect to reach a valuation of US$ 595 Mn by 2031.
  • The U.K. holds the highest share in the Europe diet pills market, while Germany is the next leading country, with these markets expected to progress at 3.6% and 3% CAGRs, respectively.

“Growing prevalence of obesity, unhealthy lifestyle, and rising awareness regarding preventive health are factors that have changed the focus of the pharmaceutical industry towards the development of weight loss pills,” says an analyst of Fact.MR.

europe diet pills market drug by FactMR
Increasing Number of Manufacturers Innovating Weight Management Products

Innovation has played a consistence part in the development of dietary pills, which is creating business opportunities for manufacturers. New product development with more health benefits is encouraging consumers to try novel nutrition supplements. Key players are offering dietary pills for caloric restriction to overcome weight-related risk factors such as diabetes and hypertension.

Growing prevalence of obesity has propelled manufacturers to innovate more effective diet pill supplements. Expanding technological platforms and increased research on innovative weight management products are expected to result in increased growth of the market.

Request Methodology & Get a Glimpse of Our Expertise
https://www.factmr.com/connectus/sample?flag=RM&rep_id=6494

Key Takeaways for Europe Diet Pills Market Research Report:

  • Demand for prescription-based pills for weight loss will continue rising in the U.K. Fact MR predicts overall diet pill sales in the country to surpass US$ 193 Mn by 2031.
  • Sales of diet pills in Germany will rise at 3% CAGR owing to rising concerns about health and wellness.
  • By drug class, glucomannan segment accounted for over 39.5% of the Europe market in 2020.
  • By drug type, herbal diet supplements sales totalled US$ 444.3 Mn in 2020 owing to increase in demand for organic product consumption.

Growth Drivers:

  • Rising spending on dietary supplements and nutrition are driving demand for diet pills for appetite control.
  • Expansion of distribution channels for diet pills will bolster sales opportunities in Europe.
  • Rising adoption of drugs for weight loss and obesity-control will accelerate demand for weight loss pills in Europe.
  • Increasing availability across e-commerce platforms will encourage diet pill sales in Europe.

Get More Insights-https://www.biospace.com/article/herbal-supplements-make-inroads-in-europe-diet-pills-market-with-total-sales-projected-to-surpass-us-611-6-mn-by-2031-fact-mr/

Key Restraints:

  • High cost of drug development is hindering demand for diet pills.
  • Stringent regulations imposed by research and development of obesity related drugs will restrain market growth.
  • Adoption of off-label drugs limits penetration of actual drugs which is restraining market growth.

Explore Fact.MR’s Coverage on the Healthcare Domain

Genetic Testing Services Market – The future expansion of genetic testing services is heavily reliant on the advancement of information technology. Throughout the projected period, North America is expected to dominate the worldwide genetic testing services market. Increased demand for genetic testing to determine ancestry, as well as an increase in demand for in-vitro fertilization (IVF) and pre-implantation testing, are some of the primary reasons boosting market share. According to projections, the North American genetic testing market will account for over two-fifths of the total.

Rheumatoid Arthritis Stem Cell Therapy Market – Over the forecast period, the global market for rheumatoid arthritis treatments is expected to rise moderately. Over the projected period, the allogeneic mesenchymal stem cell segment is expected to lead the global rheumatoid arthritis stem cell therapy market. As the most accessible channel, hospitals are likely to account for a sizable portion of the global rheumatoid arthritis stem cell therapy market.

Serological Transplant Diagnostics Market – Serological transplant diagnosis, which is a critical component of successful and efficient organ transplantation, has grown rapidly in recent years. Growth in important distribution channels, such as hospitals and organ transplantation centres, to name a few, has boosted demand during the last five years, from 2016 to 2020, attracting more stakeholders to the business. Serological transplant diagnostic equipment sales are being fueled by an increase in incidence of serious lung, liver, and kidney disorders, as well as medical and diagnostic developments.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/europe-diet-pills-market
Press Release: https://www.factmr.com/media-release/2100/europe-diet-pills-trends

Categories
Pharmaceutical

Interdental Cleaning Products Market is expected to reach a valuation of over US$ 4 Bn by 2031- Exclusive Report by Fact.MR

As per a new report published by Fact.MR – a market research and competitive intelligence provider, the global market for interdental cleaning products was valued at US$ 3 Bn in 2020, and is projected to top US$ 4 Bn by 2031, expanding at a CAGR of 3%. Offline sales hold 90% share of global revenue, and are expected to witness steady growth over the coming years.

Fact.MR anticipates significant surge in demand for interdental cleaning products attributable to factors such as growing oral health consciousness among consumers, efforts towards preventive dental care, government initiatives towards advanced oral health awareness, and investments into product research & development by leading market players.

Over the last decade, there has been an increase in dental problems such as plaque in between the teeth, increasing dental cavities, bad breath, and inflammation of the gums among the population worldwide. This has, in turn, fuelled product demand. Many innovative products such as dental floss, electric interdental toothbrushes, dental tapes, and tongue cleaners are being adopted by high- and middle-income people across countries.

Request a report sample to gain comprehensive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=6484

Government initiatives are playing a critical role in not only increasing access to interdental cleaning products, but also in boosting user awareness. Collaborations between governments and professional dental organizations are critical to reach a large number of potential users.

interdental cleaning products market by FactMR
Key Takeaways from Market Study
  • Key factors driving demand for interdental cleaning products are rise in prevalence of oral diseases worldwide and growing awareness towards maintaining dental hygiene.
  • Europe accounts for around 29% share of global revenue from interdental cleaning products, and demand in the region is expected to further surge across the forecast period.
  • Demand for interdental cleaning products in China is projected to top US$ 852Mn by 2031, increasing at a CAGR of 5%.
  • Owing to their usage feasibility, global demand for interdental brushes is anticipated to expand at a CAGR of 5% through 2031.
  • Offline sales hold 90% share of global revenue for interdental cleaning products, and are expected to witness significant growth over the coming years.

“Increasing awareness towards maintaining dental hygiene to surge demand for interdental cleaning products,” Says a Fact.MR analyst.

Request Methodology & Get a Glimpse of Our Expertise
https://www.factmr.com/connectus/sample?flag=RM&rep_id=6484
Sales Analysis of Interdental Cleaning Products from 2016 to 2020 Vs Demand Outlook for 2021 to 2031

As per Fact.MR – a market research and competitive intelligence provider, the global interdental cleaning products market was valued at US$ 950 Mn in 2016, and is anticipated to rise at a CAGR of 3% to top US$ 4 Bn by 2031.

Over the last decade, there has been a rise in dental problems such as plaque, dental cavities, bad breath, and inflammation of the gums across the world. This has fuelled demand for interdental cleaning products.

Increasing disposable income in developing countries such as India, China, and Japan is leading to the market growth of interdental cleaning products. Many innovative products such as dental floss, electric interdental toothbrushes, dental tapes, and tongue cleaners are being adopted by high and middle-income people.

Get More Insights-https://www.biospace.com/article/rising-cases-of-gastrointestinal-disorders-are-driving-the-nizatidine-market-fact-mr/

More Valuable Insights

Fact.MR, in its new offering, presents an unbiased analysis of the interdental cleaning products market, presenting historical market data (2016-2020) and forecast statistics for the period of 2021-2031.

The study reveals essential insights on the basis of product (interdental brushes, toothpicks, dental tapes, and dental floss) and sales channel (offline and online), across major regions of the world (North America, Europe, Asia Pacific, Central & South America, and the Middle East & Africa).

Explore Fact.MR’s Coverage on the Healthcare Domain

Genetic Testing Services Market – The future expansion of genetic testing services is heavily reliant on the advancement of information technology. Throughout the projected period, North America is expected to dominate the worldwide genetic testing services market. Increased demand for genetic testing to determine ancestry, as well as an increase in demand for in-vitro fertilization (IVF) and pre-implantation testing, are some of the primary reasons boosting market share. According to projections, the North American genetic testing market will account for over two-fifths of the total.

Rheumatoid Arthritis Stem Cell Therapy Market – Over the forecast period, the global market for rheumatoid arthritis treatments is expected to rise moderately. Over the projected period, the allogeneic mesenchymal stem cell segment is expected to lead the global rheumatoid arthritis stem cell therapy market. As the most accessible channel, hospitals are likely to account for a sizable portion of the global rheumatoid arthritis stem cell therapy market.

Serological Transplant Diagnostics Market – Serological transplant diagnosis, which is a critical component of successful and efficient organ transplantation, has grown rapidly in recent years. Growth in important distribution channels, such as hospitals and organ transplantation centres, to name a few, has boosted demand during the last five years, from 2016 to 2020, attracting more stakeholders to the business. Serological transplant diagnostic equipment sales are being fueled by an increase in incidence of serious lung, liver, and kidney disorders, as well as medical and diagnostic developments.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/interdental-cleaning-products-market
Press Release: https://www.factmr.com/media-release/2096/global-interdental-cleaning-products-trends

Categories
Pharmaceutical

Compound Houttuyina Market is Registering a CAGR Exceeding 10% Across the 2021-2031 Forecast Period

Fact.MR’s global compound houttuynia market report predicts a highly optimistic outlook for the 2021-2031 forecast period, estimating a CAGR exceeding 10% to reach a multi-million dollar valuation. Extensive uptake of alternative and herbal medicine is acting as the primary growth catalyst for the market.

Historically, the market expanded at a CAGR of approximately 10% from 2016 to 2020. Herbal medicine is being extensively adopted to address conditions such as respiratory disorders and other infectious ailments. Additionally, they are also proving to be effective against various forms of cancers.

According to GLOBOCAN 2020, worldwide, an estimated 19.3 million new cancer cases, 18.1 million excluding non-melanoma skin cancer, and almost 10.0 million cancer deaths excluding non-melanoma skin cancer occurred in 2020.Lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancer.

Uptake of compound houttuynia products is expected to incline significantly, with manufacturers deepening penetration across key markets such as China, India, and Japan.

For more Insights into the Market, Request a Sample of this Report
https://www.factmr.com/connectus/sample?flag=S&rep_id=6324

According to Fact.MR’s analysis, the global conductive plastic compound market is expected to exceed a valuation of US$ 20.5 billion by 2031-end.

“Increasing application of conductive plastic compounds in automotive and electrical & electronics industry have prompted the manufacturers to come up with sustainable solution and strategies to improve their revenue across developed nations,” says a Fact.MR analyst. 

compound houttuynia market

Key Takeaways

  • The conductive plastic compounds market is expected to grow two-fold by 2031-end
  • Increased application in building & construction will spur sales
  • In terms of end-use, electric & electrical segment will witness substantial growth for the sale of conductive plastic compounds
  • Carbon nanotubes based fillers are expected to witness high demand backed by extensive usage in electric & electrical industry
  • China is expected to hold the largest market share owing to the surging demand of conductive plastic compounds in electric as well as automotive sector
  • UK and Germany will witness sluggish growth due to the stringent policies for the use of non-biodegradable plastics
  • Steady rise in demand due to increased application in automotive industry will spur the sales of conductive plastic compounds across the U.S.

Request Methodology & Get a Glimpse of Our Expertise
https://www.factmr.com/connectus/sample?flag=RM&rep_id=6324

Competitive Landscape        

Product innovation, expansion of product portfolios, strategic partnerships & collaborations with top companies are some of the strategies prominent players rely on to expand their regional as well as global footprints in the industry.

For instance, Novation Solutions LLC, a materials science company that specializes in high-silicone dispersions, in January 2021, announced the launch of PURmix high-consistency rubber (HCR), healthcare plastic compound that enhances electrical properties of silicone rubber, using patent-pending technologies that incorporate a revolutionary single-wall carbon nanotube developed by Zeon Corporation.

In June 2020, Clariant Plastics & Coatings Healthcare Polymer Solutions announced the launch of static-reducing functional plastic compounds, which are able to increase dose reliability when used in drug delivery devices. The plastic compounds are part of the wider medical grade and includes polymers from PE to PEEK.

On March 16th 2021, Green Mantra Technologies, a global innovation leader that utilizes its advanced recycling technology to create unique specialty polymers and plastic compounds from discarded plastics, announced the partnership with HARKE Group, a leading distributor of specialty chemicals in Europe. Through this partnership, the companies aim to expand their customer base on the back of its sustainable solutions.

The compound houttuynia landscape appears to be highly consolidated, characterized by the presence of a majority of Chinese manufacturers. Offering new products remains the primary strategy of key market players.
Get More Insights-https://www.biospace.com/article/compound-houttuyina-market-surging-at-7-percent-cagr-increasing-application-in-natural-medicines-spurring-growth-170-pages-market-research-survey-by-fact-mr-a-market-research-and-competitive-intelligence-provider-/
More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the compound houttuynia market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of type (tablets, mixture, capsules, and others) and distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa).

Explore Fact.MR’s Coverage on the Healthcare Domain

Genetic Testing Services Market – The future expansion of genetic testing services is heavily reliant on the advancement of information technology. Throughout the projected period, North America is expected to dominate the worldwide genetic testing services market. Increased demand for genetic testing to determine ancestry, as well as an increase in demand for in-vitro fertilization (IVF) and pre-implantation testing, are some of the primary reasons boosting market share. According to projections, the North American genetic testing market will account for over two-fifths of the total.

Rheumatoid Arthritis Stem Cell Therapy Market – Over the forecast period, the global market for rheumatoid arthritis treatments is expected to rise moderately. Over the projected period, the allogeneic mesenchymal stem cell segment is expected to lead the global rheumatoid arthritis stem cell therapy market. As the most accessible channel, hospitals are likely to account for a sizable portion of the global rheumatoid arthritis stem cell therapy market.

Serological Transplant Diagnostics Market – Serological transplant diagnosis, which is a critical component of successful and efficient organ transplantation, has grown rapidly in recent years. Growth in important distribution channels, such as hospitals and organ transplantation centres, to name a few, has boosted demand during the last five years, from 2016 to 2020, attracting more stakeholders to the business. Serological transplant diagnostic equipment sales are being fueled by an increase in incidence of serious lung, liver, and kidney disorders, as well as medical and diagnostic developments.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/compound-houttuynia-market
Press Release: https://www.factmr.com/media-release/2011/global-compound-houttuynia-market

Categories
Pharmaceutical

Nizatidine Market is Projected to Expand at more than 9% CAGR over the Forecast Period 2021 to 2031

Award-winning consulting firm Fact.MR’s recently published report on the global demand of nizatidine market for the forecast period 2021-2031 expects an optimistic future outlook, projecting noteworthy growth for the said period. Growth is expected to be primarily fueled by extensive application in gastric disorder treatment.

According to a study published by a group of researchers at the University of Gothenburg, nearly 40% of adults suffer from a functional gastrointestinal disorder in a 73,000 person, 33 country survey. Functional gastrointestinal disorders represent a series of chronic disorders in the gastrointestinal tract that often include severe symptoms such as heartburn, acid reflux, and dyspepsia in the upper gastrointestinal tract.

Request a report sample to gain comprehensive insights at:
https://www.factmr.com/connectus/sample?flag=S&rep_id=6217

The market experienced hiccups in the recent past amid a series of product recalls by prominent manufacturers due to several compliance incompatibilities. However, these withdrawals have been overturned, reopening growth frontiers. For instance, in September 2020, Amneal Pharmaceuticals Inc. announced that its nizatidine oral solution 15 mg/ml was available for reorder across the U.S., meeting all FDA requirements.

Key Takeaways from Market Study
  • By type, nizatidine capsules of doses of 150 mg and 300 mg to remain most preferred
  • Retail and online sales of nizatidine products to experience massive incline over coming years
  • Resumption of regulatory approval grants to stimulate nizatidine sales across the U.S.
  • India to attract significant investments, attributed to high domestic manufacturing capabilities of generic drugs
  • China to generate high demand amid rising prevalence of gastric cancer and irritable bowel syndrome
nizatidine market
“Surging healthcare costs associated with availing high-grade gastrointestinal disorder treatment are prompting a shift towards consuming orally administered nizatidine capsules and tablets, ”says a Fact.MR analyst
Request Methodology & Get a Glimpse of Our Expertise
https://www.factmr.com/connectus/sample?flag=RM&rep_id=6217
Competitive Landscape

Major players in the market that are associated with offering nizatidine-based formulations and nizatidine, in itself, include Flynn Pharma, MedChemExpress, Mylan N.V., Glenmark Pharmaceuticals, Weightech (Hunan) Pharmaceutical, Hengdian Group, Dr. Reddy’s Laboratories, Eli Lily and Company, and Strides Pharma Science Limited.

These aforementioned players largely concentrate on offering different formulations of nizatidine so as to especially cater to gastrointestinal ailments. A majority of these players are scrambling to acquire regulatory approvals from appropriate authorities to secure a firm footing in the market across regions and increased their revenue and profit margins.

Key Takeaways

  • National Centre for Biotechnology Information (NCBI) states that China exhibits high incidence of irritable bowel syndrome (IBS), which affects 4-7% of the population. These figures point towards an increasing scope for the need of nizatidine drugs.
  • Increasing focus on health and wellness and resultantly rising healthcare spending is creating growth prospects within the U.S.
  • According to reports by India Brand Equity Foundation (IBEF), India is the largest global supplier of generic drugs. Hence, the market is expected to surge by 9%, showing greater expansion prospects.
  • Sales of nizatidine capsules are expected to surge at over 10% CAGR over the forecast period
Get More Insights- https://www.biospace.com/article/rising-cases-of-gastrointestinal-disorders-are-driving-the-nizatidine-market-fact-mr/
More Insights on the Nizatidine Market

Fact.MR, in its new offering, presents an unbiased analysis of the nizatidine treatment market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of type (capsules, tablets, and others) and application (hospital pharmacies, retail pharmacies, and online pharmacies) across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The report provides qualitative and quantitative information on various players in this market. This report also tracks the market by both, supply side and demand side trends.

Explore Fact.MR’s Coverage on the Healthcare Domain

Genetic Testing Services Market – The future expansion of genetic testing services is heavily reliant on the advancement of information technology. Throughout the projected period, North America is expected to dominate the worldwide genetic testing services market. Increased demand for genetic testing to determine ancestry, as well as an increase in demand for in-vitro fertilization (IVF) and pre-implantation testing, are some of the primary reasons boosting market share. According to projections, the North American genetic testing market will account for over two-fifths of the total.

Rheumatoid Arthritis Stem Cell Therapy Market – Over the forecast period, the global market for rheumatoid arthritis treatments is expected to rise moderately. Over the projected period, the allogeneic mesenchymal stem cell segment is expected to lead the global rheumatoid arthritis stem cell therapy market. As the most accessible channel, hospitals are likely to account for a sizable portion of the global rheumatoid arthritis stem cell therapy market.

Serological Transplant Diagnostics Market – Serological transplant diagnosis, which is a critical component of successful and efficient organ transplantation, has grown rapidly in recent years. Growth in important distribution channels, such as hospitals and organ transplantation centres, to name a few, has boosted demand during the last five years, from 2016 to 2020, attracting more stakeholders to the business. Serological transplant diagnostic equipment sales are being fueled by an increase in incidence of serious lung, liver, and kidney disorders, as well as medical and diagnostic developments.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/nizatidine-market
Press Release: https://www.factmr.com/media-release/2003/global-nizatidine-market 

Categories
Pharmaceutical

Demand for Plastic Blood Collection Tubes for Liquid Biopsy Is Poised to See a Healthy Growth Outlook at 6% CAGR During 2019 – 2029

Surpassing revenues worth US$ 215 Mn in 2019, sales of blood collection tubes for liquid biopsy are poised to see a healthy growth outlook at 6% CAGR during 2019 – 2029. Despite being an essential diagnostic product in the practice of laboratory biopsy testing, the blood collection tubes for liquid biopsy market is still young, and the application scope remains majorly limited to research industry.

High product availability is limited to developed regions such as North America, Europe, and Oceania. However, increased application of blood collection tubes for liquid biopsy in genetic diagnostics and other common diagnostic procedures is likely to bolster demand for blood collection tubes for liquid biopsy in following years.

The healthcare industry is consistently witnessing an increase in the number of biopsy procedures every year, globally, due to the increasing prevalence of cancer. Growing awareness and rise in cancer screening procedures has led to the growth of the blood collection tubes for liquid biopsy market which in turn has increased the rate of early diagnosis of cancer.

For More Insights Into The Market, Request a Sample of this Report –
https://www.factmr.com/connectus/sample?flag=S&rep_id=4495

Key Segments of the Blood Collection Tubes for Liquid Biopsy Market

Fact.MR’s study on the blood collection tubes for liquid biopsy market offers information divided into four important segments-product, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Products
  • Plastic
  • Glass
Application
  • IVD
  • Research Use
End User
  • Healthcare Centers
  • R&D Centers
  • Diagnostic Centers
Region
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Access Research Methodology Prepared By Experts –
https://www.factmr.com/connectus/sample?flag=AE&rep_id=4495

Key Takeaways – Blood Collection Tubes for Liquid Biopsy

  • Healthcare centers would show remarkable growth in adoption of blood collection tubes for liquid biopsy owing to the rise in number of research activities.
  • Increasing prevalence of cancers will remain one of the major factors responsible for the growth of the blood collection tubes for liquid biopsy market.
  • Blood collection tubes for liquid biopsy market is a fragmented landscape.
  • Growing demand for single needle penetration for multiple tests is identified as the key growth engine, pushing adoption of blood collection tubes for liquid biopsy.

Key Players

  • Roche
  • Streck
  • Preanalytix
  • Norgen Biotek
  • Biocept

blood collection tubes for liquid biopsy market 02

Plastic Tubes Remain Highly Sought-after

On back of higher safety standards, plastic blood collection tubes for liquid biopsy will continue to gather preference over their glass counterparts. The former remains preferred for their greater reliability during routine clinical chemistry analysis, tumor screening, biopsy tests and chemotherapeutic drug monitoring. The shatter-resistant plastic further reduces the risk of exposure to pathogens and contamination.

Attractiveness of Asian Markets Intact

Growth opportunities for the blood collection tubes for liquid biopsy market players is picking up the pace in the East and South Asian regions. Increasing availability of economically affordable blood collection tubes would also be a significant booster to market growth. A large number of local manufacturers, particularly in China, Japan, and India, are increasing the scope for manufacturers and boosting the blood collection tubes for liquid biopsy market growth.

Full Access of this Report Is Available at
https://www.factmr.com/checkout/4495

Know More About Blood Collection Tubes for Liquid Biopsy Market

Fact.MR’s business intelligence also underlines groundbreaking insights into the competitive scenario of the blood collection tubes for liquid biopsy market, along with highlights of manufacturers’ differential strategies. The blood collection tubes for liquid biopsy market is majorly covered by the players offering conventional blood collection tubes for liquid biopsy. The key players’ operating in the blood collection tubes for liquid biopsy market will continue to focus on delivering of their products through direct sales and distribution channels.

Key Questions Answered in Fact.MR’s Blood Collection Tubes for Liquid Biopsy Market Report

  • Which regions will continue to remain the most profitable for blood collection tubes for liquid biopsy market players?
  • Which factors will induce a change in the demand for blood collection tubes for liquid biopsy during the assessment period?
  • How will the changing trends impact the blood collection tubes for liquid biopsy market?
  • How will the market players capture the untapped market opportunities in the blood collection tubes for liquid biopsy market?
  • How local players’ products will impact the adoption of blood collection tubes for liquid biopsy?

For More Insights 
https://www.biospace.com/article/bell-s-palsy-treatment-demand-propelled-by-growing-prevalence-of-bell-s-palsy-says-fact-mr

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Demand for Home-based Behavioural Health Treatment Services Is Estimated CAGR of 2.4% Over the Assessment Period

Big data and analytics will drive patient outcomes in a big way, and the coming years will witness a growing emphasis on healthcare service providers in the business of gathering and processing patient health data. Creating outcome-oriented financial models to maximize reimbursements in value-based healthcare will be a strategic shift from the traditional fees-for-services model. This implies that pharmaceutical companies will need to devise appropriate measures to optimize costs and improve the quality of patient care.

Burden of mental illness on Europe’s economy is among the largest in the world, inadvertently making it the most lucrative region for players in the behavioural health treatment market, with the region slated to account for a staggering 47% of the global market by 2027. Total cost associated with mental health treatment amounted to around US$ 668 Bn in 2018 across the EU, translating to 4% of the GDP of Europe. Taking cue from this opportunity, key players are striving to expand their treatment facilities to offer easy accessibility to patients.

For More Insights Into The Market, Request a Sample of this Report –

https://www.factmr.com/connectus/sample?flag=S&rep_id=4370

However, uneven distribution of therapy facilities and rehabilitation centres in rural regions across the globe is projected to result in sluggish growth of the behavioural health treatment market, with an estimated CAGR of 2.4% during the forecast period (2020-2027).

A senior analyst at Fact.MR opines,“Advent of on-demand service model will remain crucial for the behavioural health treatment market, especially in developing regions, on account of high social stigma related to opting for mental health therapy. Additionally, value-based subscription models offered by on-demand counselling would be easy on the pockets of patients, which is projected to drive a massive shift from hospital and outpatient-based care to home-based care.”

Key Takeaways of Behavioural Health Treatment Market Study

  • According to WHO, 800,000 suicides are recorded every year, on the back of depression and anxiety disorders. Symptoms of depression are found to be high among millennial cohort as compared to other age groups, influenced by reckless use of social media and stressful lifestyles. Revenue generation through patient base suffering from depression is projected to grow by 3.2% in 2027 over 2026.
  • Individuals will continue to show a high interest in outpatient counselling services, as these programs offer freedom of movement over inpatient hospital treatment services. Given the high relevance of this influence, outpatient counselling services are projected to witness a marginal rise, at a CAGR of around 2.7% during the forecast period.
  • Social stigma associated with mental health discourages individuals from seeking proper treatment and counselling, which could hinder behavioural health treatment market growth during the forecast period.
  • Asia Pacific is projected to record the highest growth rate of nearly 2.8% during 2020-2027, which is attributable to increase in service centres and debunking of mental health taboos through awareness campaigns by various government and non-governmental organizations.

Access Research Methodology Prepared By Experts –

https://www.factmr.com/connectus/sample?flag=S&rep_id=4370

Behavioural Health Treatment Market – Assessment of Key Segments

Disorder
  • Depression
  • Anxiety
  • Schizophrenia
  • Bipolar Disorder
  • Alcohol Use Disorders
  • Substance Use Disorders
  • Eating Disorders
  • Post-traumatic Stress Disorders
  • Others
Service
  • Inpatient Hospital Treatment Services
  • Outpatient Counselling
  • Emergency Mental Health Services
  • Home-based Treatment Services
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Full Access of this Report Is Available At

https://www.factmr.com/checkout/4370

market share estimation of key regions in behavioural health treatment market

Key Players Listed in this Comprehensive Report on the Behavioural Health Treatment Market Include

Although the behavioural health treatment market boasts of a number of organized players, numerous individual practitioners operating at regional and local levels generate a significant chunk of revenue. Lack of stringent regulations for practicing behavioural health services reduces the entry barrier in the market, and further adds a layer of fragmentation to the behavioural health treatment market.

Key focus of players to strengthen their foothold in the behavioural health treatment market remains on the expansion of inpatient care facilities. For instance, in January 2019, Acadia Healthcare announced the acquisition of Whittier Pavilion, which is an inpatient psychiatric facility with 71 beds. In May 2019, MercyOne Central Iowa and Universal Health Services, Inc. established a new facility at Iowa, with 100 beds, to offer high quality services for behavioural health.

  • Promises Behavioural Health
  • Pyramid Healthcare
  • Acadia Healthcare
  • Ascension Seton
  • CareTech Holdings PLC
  • STRATEGIC BEHAVIOURAL HEALTH
  • The MENTOR Network
  • North Range Behavioural Health
  • Universal Health Services Inc.
  • Behavioural Health Network Inc.

For More Insights https://www.biospace.com/article/bone-marrow-processing-systems-growth-driven-by-progressions-in-bone-marrow-needles-and-harvest-technology-says-fact-mr/

Find More Valuable Insights on Behavioural Health Treatment Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global behavioural health treatment market, presenting historical demand data (2017-2019), and forecast statistics for the period 2020-2027. The study divulges compelling insights on the behavioural health treatment market on the basis of disorder (depression, anxiety, schizophrenia, bipolar disorder, alcohol use disorders, substance use disorders, eating disorders, post-traumatic stress disorders (PSTD), and others), service (inpatient hospital treatment services, outpatient counselling, emergency mental health services, home-based treatment services, and others), across five major regions.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Demand for NGS-Based Predictive Diagnostics Is Expected to Remain Significantly High In North America : Fact.MR

Mass technological transformation of the global healthcare industry has left key market participants struggling to traverse the complexities of medical and life sciences. Given the shifting dynamics of the global healthcare sector, pharma and biotech companies are taking measured efforts to improve patient outcomes in an effective manner, while keeping a careful watch on the bottom line.

For the area of medical diagnosis, accuracy and precision are inevitable. This has triggered healthcare companies to resort to predictive diagnostic tools that can amplify the precision as well as reliability of diagnostics, and help healthcare providers to improve their patient care and medical outcomes.

The global sales of predictive diagnostics are expected to reach the valuation of over US$ 3 billion by 2031, finds a recent study published by Fact.MR. The study opines that the convergence of healthcare practices and next-generation technologies will take an upsurge in the coming years, and this will make predictive diagnostics the ‘New Normal’ in the healthcare industry in the coming future.

Predictive diagnostics is one of the most prominent applications of Artificial Intelligence and advanced data technologies in the healthcare domain. Predictive diagnostics also play an important role in identifying the patients’ reaction to different treatments, which can ultimately help healthcare providers to dramatically improve medical outcomes. Constant advancements in the technologies will further strengthen the demand for predictive diagnostics, reiterating the positive growth potential for stakeholders in the market, opines the Fact.MR study.

For More Insights Into The Market, Request a Sample of this Report –

https://www.factmr.com/connectus/sample?flag=S&rep_id=5509

“Personalized treatments and precision medicines are among the top, fast-growing trends in the healthcare industry, and these are the salient factors that are contributing to the growth of the predictive diagnostics market. Doctors, physicians, pathologists among all the other healthcare service providers are making a move towards diagnostic tools that can offer maximum reliability to incur positive medical outcomes at a lower cost. This fortifies the role of technology and innovation in the predictive diagnostics market. In the coming years, Manufacturers in the predictive diagnostics market must benefit from this trend by increasing awareness in the healthcare domains of developing economies,” says a lead analyst at Fact.MR.

Key Takeaways

  • Growing adoption of advanced technologies in the healthcare industry indicates the potential for growth in the predictive diagnostics market. By 2031, the global market for predictive diagnostics is expected to surpass the valuation of US$ 3 billion, creating new opportunities for diagnostic tools with high accuracy and precision in the coming decade.
  • The predictive diagnostics market is expected to grow at a CAGR of around 10% between 2021 and 2031. Manufacturers are expected to innovate around the adoption of technologies to predict the risks of various diseases such as cancer, neurological disorders, etc.
  • Based on test types, the adoption of predictive diagnostics based on polymerase chain reaction (PCR) tests is expected to remain high, which manufacturers are slowly moving towards next-generation sequencing (NGS) platforms by integrating advanced technologies in their tools.
  • With the growing demand for predictive diagnostic tools for identifying the risks of various types of cancer, manufacturers in the predictive diagnostics market are upscaling the production and research & development effort to discover accurate predictive tests for cancer.
  • The demand for predictive diagnostics is expected to remain significantly high in developed regions, especially in North America. Growing presence of market leaders and increasing healthcare spending in the United States makes the region a profitable market for manufacturers and other stakeholders.

Access Research Methodology Prepared By Experts –

https://www.factmr.com/connectus/sample?flag=RM&rep_id=5509

predictive diagnostics market regional analysis by FactMR

Key Players

Key players in the global predictive diagnostics market are Abbott Laboratories, Therawis, F.Hoffmann-La Roche Ltd., BIOMÉRIEUX SA, Agilent Technologies, Illumina, Inc., Thermo Fisher Scientific, Inc., Bio-Rad, Myriad Genetics, Inc., Genesis Genetics, Centogene N.V., BGI, 23andMe, Inc., Predictive Oncology, Counsyl, Inc., Bio-Rad Laboratories Inc., Mylab Discovery Solutions Pvt. Ltd., and ARUP Laboratories.

Predictive Diagnostics for Breast and Ovarian Cancer – A Key Trend

The incidence of genetically transferred cancer types such as breast cancer and ovarian cancer has increased dramatically in the past few years. According to the World Cancer Research Fund, over 2 million new cases of breast cancer and more than 300,000 new cases of ovarian cancer were recorded across the world in 2018.

Also, cancer is one of the leading causes of death, which makes it important for healthcare providers to use high-tech predictive diagnostics to identify risks of cancer in individuals. This is one of the key factors that are likely to trigger this trend in the predictive diagnostics market.

Full Access of this Report Is Available At

https://www.factmr.com/checkout/5509

More Valuable Insights on the Predictive Diagnostics Market

The recent study published by Fact.MR provides detailed insights into how the global market for predictive diagnostics is likely to develop during the period of 2021 to 2031. The report also offers actionable insights for manufacturers and other stakeholders to devise appropriate strategies to win in the global predictive diagnostics market in the coming years.

Fact.MR’s report categorizes the insights on the predictive diagnostics market based on tests (PCR based and NSG (Sequencing) based), indication (cancer, metabolic disorders, neurological disorders, musculoskeletal disorders, and others), end users (diagnostics, genetic laboratories and clinics, and research and academic institutes) and seven regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa).

Key Questions Answered

  • Predictive diagnostics for which indications will witness high adoption across the world?
  • What are the key challenges encountered by the new entrants in the global predictive diagnostics market?
  • Which factors may hinder the growth of the global predictive diagnostics market in the coming decade?
  • What are the upcoming trends in the predictive diagnostics market that redefine its growth?
  • Which strategies will help manufacturers to consolidate a strong position in the market for predictive diagnostics in North America?

For More Insights

https://www.biospace.com/article/emergence-of-new-age-testing-facilities-and-methods-are-playing-key-role-in-increased-uptake-of-carbapenem-resistant-enterobacteriaceae-testing-market-notes-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com